Skip to main content
PTIX
OTC Life Sciences

Micro-Cap Biotech Raises $1.5M Upfront, Up to $5M, to Fund First U.S. Anxiety Trial

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.493
Mkt Cap
$893.247K
52W Low
$0.128
52W High
$4.43
52W Position info
285% above low
Off High info
89% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

PTIX has more than doubled off its 52-week low of $0.128 on light trading volume (0.4× avg).

Summary

Protagenic pulled in $1.5M in upfront gross proceeds from a private placement with new and existing investors, with up to $3.5M more if two series of milestone-linked warrants are exercised in full, for up to $5M total before fees. The initial closing issued 2,459,014 shares plus Series A warrants at $0.67 and Series B warrants at $0.73, with subsequent closings allowed until December 31, 2026. The cash is earmarked for IND-enabling work on PT00114, starting the Phase 1/2a trial in generalized anxiety disorder, and working capital. This comes after the August 20 8-K disclosing FDA pre-IND feedback with no deficiencies blocking an IND, and it addresses the going-concern warning and thin cash position flagged in the August 19 10-Q. The company targets first patient dosing in Q2 2027, topline safety data in H2 2027 and exploratory efficacy data in H1 2028. The upfront $1.5M is small relative to the full trial cost, and management explicitly says it continues to pursue strategic options and additional capital, so further dilution is likely.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Initial closing issued 2,459,014 shares plus Series A warrants at $0.67 and Series B warrants at $0.73, with subsequent closings allowed until December 31, 2026.

At the time of this announcement, PTIX was trading at $0.49 on OTC in the Life Sciences sector, with a market capitalization of approximately $893.2K. The 52-week trading range was $0.13 to $4.43. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

PTIX - Latest Insights

PTIX
Nov 17, 2026, 4:41 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4575
Real-time Price: $0.4575 info
Change: $0 (0%) info
Market Cap: $828.171K info
PTIX
Aug 20, 2026, 11:26 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.400
Real-time Price: $0.4575 info
Change: +$0.0575 (+14%) info
Market Cap: $828.171K info
PTIX
Aug 19, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.350
Real-time Price: $0.4575 info
Change: +$0.1075 (+31%) info
Market Cap: $828.171K info
PTIX
Aug 14, 2026, 3:19 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.360
Real-time Price: $0.4575 info
Change: +$0.0975 (+27%) info
Market Cap: $828.171K info
PTIX
Apr 06, 2026, 7:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.530
Real-time Price: $0.4575 info
Change: -$0.0725 (-14%) info
Market Cap: $828.171K info